Abstract
Overview
Introduction
Waves of technological advancements have powered significant evolution in R&D from serendipitous drug discovery, through to rational drug design. However, as the low-hanging fruit has been picked, and recent technological advances have failed to yield high numbers of new therapies, the search is on to identify R&D strategies to improve R&D productivity
Scope of this report
- Overview of the pressures facing drug developers, including an analysis of whether the industry is facing an R&D productivity crisis
- In-depth analysis of R&D deal activity, together with a pipeline snapshot, to identify trends that are shaping the R&D environment
- Identification of strategy optimization recommendations designed to drive up R&D productivity
- Evaluation of case-studies of Big Pharma R&D strategies to determine how these companies are addressing the productivity problem
View Cart
